Wyeth Reports Earnings Results for the 2007 Third Quarter and First N...(lower inventory levelsand increased 5% f...),Health

Date:10/18/2007

lower inventory levels, and increased 5% for the 2007 first nine months. The increase in Pharmaceuticals net revenue was offset, in part, by lower sales of Inderal(R) LA due to generic competition. Alliance revenue decreased 12% to $314 million for the 2007 third quarter due to lower alliance revenue associated with sales of the CYPHER stent and Altace. For the 2007 first nine months, alliance revenue increased slightly to $973 million due to higher sales of Enbrel in the United States and Canada, which were partially offset by lower alliance revenue associated with sales of the CYPHER stent and Altace. Excluding the favorable impact of foreign exchange, worldwide Pharmaceuticals net revenue increased 7% for the 2007 third quarter and 8% for the 2007 first nine months.

Consumer Healthcare

Worldwide Consumer Healthcare net revenue increased 8% for the 2007 third quarter due primarily to an increase in sales of Advil(R), Advil(R) PM, and Caltrate(R). Net revenue increased 7% for the 2007 first nine months due primarily to an increase in sales of Centrum(R), Advil, Advil PM, and Caltrate. Excluding the favorable impact of foreign exchange, worldwide Consumer Healthcare net revenue increased 4% for the 2007 third quarter and first nine months.

Animal Health

Worldwide Animal Health net revenue increased 11% for the 2007 third quarter due to higher sales of livestock, poultry and companion animal products, which included sales of our recently launched ProMeris(R) flea and tick products. Net revenue for the 2007 first nine months increased 8% due to higher sales of livestock, poultry, companion animal and equine products. Excluding the favorable impact of foreign exchange, worldwide Animal Health net revenue increased 6% for the 2007 third quarter and 4% for the 2007 first nine months.

Results of Operations

The comparative results of operations are as follows:

(In thousands except per share amounts)

'/>"/>

SOURCE Wyeth Copyright©2007 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13
Related medicine news :

1. Wyeth Launches Vaccine for Pneumococcal Disease in India
2. Wyeth Embroiled in a Lawsuit over its Hormone Replacement Therapy
3. Wyeth Pharma Wins Law Suit
4. Verdict Against Wyeth Pharma in Prempro Case
5. FDA Approves Wyeths Oral Contraceptive Lybrel
6. Autopsy reports could be valuable and informative
7. China reports declining number of SARS Cases
8. Russia Reports First SARS Case
9. Research reports that c-section deliveries are rising
10. Jharkhand reports 13,000 Malaria cases
11. Uganda Reports Failure To Contain Sleeping Sickness